SEI Investments
LYEL icon

SEI Investments’s Lyell Immunopharma LYEL Stock Holding History

SEI Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,795
Closed -$30.1K – 2863
2025
Q1 		$30.1K Hold
2,795
– – ﹤0.01% 2718
2024
Q4 		$35.8K Hold
2,795
– – ﹤0.01% 2690
2024
Q3 		$77.1K Buy
+2,795
New +$82.1K ﹤0.01% 2594
2022
Q4 		– Sell
-735
Closed -$108K – 2617
2022
Q3 		$108K Sell
735
-25
-3% -$3.38K ﹤0.01% 2552
2022
Q2 		$99K Buy
+760
New +$77.7K ﹤0.01% 2570

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return